+1 (704) 266-3234

Global Anti-PD-1 MAb Market Growth 2020-2025

Published on: Aug 2020 | From USD $3660 | Published By: QY RESEARCH JAPANESE | Number Of Pages: 138

According to this study, over the next five years the Anti-PD-1 MAb market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-PD-1 MAb business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-PD-1 MAb market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Anti-PD-1 MAb, covering the supply chain analysis, impact assessment to the Anti-PD-1 MAb market size growth rate in several scenarios, and the measures to be undertaken by Anti-PD-1 MAb companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
40mg
100mg
200mg
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bristol Myers Squibb
Merck
Innovent Biologics Inc
Hengrui Medicine
Junshi Pharma
Beijing Beigene
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Anti-PD-1 MAb consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Anti-PD-1 MAb market by identifying its various subsegments.
Focuses on the key global Anti-PD-1 MAb manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anti-PD-1 MAb with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anti-PD-1 MAb submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-PD-1 MAb Consumption 2015-2025
2.1.2 Anti-PD-1 MAb Consumption CAGR by Region
2.2 Anti-PD-1 MAb Segment by Type
2.2.1 40mg
2.2.2 100mg
2.2.3 200mg
2.2.4 Others
2.3 Anti-PD-1 MAb Consumption by Type
2.3.1 Global Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
2.3.2 Global Anti-PD-1 MAb Revenue and Market Share by Type (2015-2020)
2.3.3 Global Anti-PD-1 MAb Sale Price by Type (2015-2020)
2.4 Anti-PD-1 MAb Segment by Application
2.4.1 Melanoma Patients
2.4.2 Lung Cancer Patients
2.4.3 Lymphoma Patients
2.4.4 Other
2.5 Anti-PD-1 MAb Consumption by Application
2.5.1 Global Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
2.5.2 Global Anti-PD-1 MAb Value and Market Share by Type (2015-2020)
2.5.3 Global Anti-PD-1 MAb Sale Price by Type (2015-2020)

3 Global Anti-PD-1 MAb by Company
3.1 Global Anti-PD-1 MAb Sales Market Share by Company
3.1.1 Global Anti-PD-1 MAb Sales by Company (2018-2020)
3.1.2 Global Anti-PD-1 MAb Sales Market Share by Company (2018-2020)
3.2 Global Anti-PD-1 MAb Revenue Market Share by Company
3.2.1 Global Anti-PD-1 MAb Revenue by Company (2018-2020)
3.2.2 Global Anti-PD-1 MAb Revenue Market Share by Company (2018-2020)
3.3 Global Anti-PD-1 MAb Sale Price by Company
3.4 Global Anti-PD-1 MAb Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Anti-PD-1 MAb Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Anti-PD-1 MAb Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti-PD-1 MAb by Regions
4.1 Anti-PD-1 MAb by Regions
4.2 Americas Anti-PD-1 MAb Consumption Growth
4.3 APAC Anti-PD-1 MAb Consumption Growth
4.4 Europe Anti-PD-1 MAb Consumption Growth
4.5 Middle East & Africa Anti-PD-1 MAb Consumption Growth

5 Americas
5.1 Americas Anti-PD-1 MAb Consumption by Countries
5.1.1 Americas Anti-PD-1 MAb Consumption by Countries (2015-2020)
5.1.2 Americas Anti-PD-1 MAb Value by Countries (2015-2020)
5.2 Americas Anti-PD-1 MAb Consumption by Type
5.3 Americas Anti-PD-1 MAb Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Anti-PD-1 MAb Consumption by Regions
6.1.1 APAC Anti-PD-1 MAb Consumption by Regions (2015-2020)
6.1.2 APAC Anti-PD-1 MAb Value by Regions (2015-2020)
6.2 APAC Anti-PD-1 MAb Consumption by Type
6.3 APAC Anti-PD-1 MAb Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Anti-PD-1 MAb by Countries
7.1.1 Europe Anti-PD-1 MAb Consumption by Countries (2015-2020)
7.1.2 Europe Anti-PD-1 MAb Value by Countries (2015-2020)
7.2 Europe Anti-PD-1 MAb Consumption by Type
7.3 Europe Anti-PD-1 MAb Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Anti-PD-1 MAb by Countries
8.1.1 Middle East & Africa Anti-PD-1 MAb Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Anti-PD-1 MAb Value by Countries (2015-2020)
8.2 Middle East & Africa Anti-PD-1 MAb Consumption by Type
8.3 Middle East & Africa Anti-PD-1 MAb Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti-PD-1 MAb Distributors
10.3 Anti-PD-1 MAb Customer

11 Global Anti-PD-1 MAb Market Forecast
11.1 Global Anti-PD-1 MAb Consumption Forecast (2021-2025)
11.2 Global Anti-PD-1 MAb Forecast by Regions
11.2.1 Global Anti-PD-1 MAb Forecast by Regions (2021-2025)
11.2.2 Global Anti-PD-1 MAb Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Anti-PD-1 MAb Forecast by Type
11.8 Global Anti-PD-1 MAb Forecast by Application

12 Key Players Analysis
12.1 Bristol Myers Squibb
12.1.1 Company Information
12.1.2 Anti-PD-1 MAb Product Offered
12.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bristol Myers Squibb Latest Developments
12.2 Merck
12.2.1 Company Information
12.2.2 Anti-PD-1 MAb Product Offered
12.2.3 Merck Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merck Latest Developments
12.3 Innovent Biologics Inc
12.3.1 Company Information
12.3.2 Anti-PD-1 MAb Product Offered
12.3.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Innovent Biologics Inc Latest Developments
12.4 Hengrui Medicine
12.4.1 Company Information
12.4.2 Anti-PD-1 MAb Product Offered
12.4.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hengrui Medicine Latest Developments
12.5 Junshi Pharma
12.5.1 Company Information
12.5.2 Anti-PD-1 MAb Product Offered
12.5.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Junshi Pharma Latest Developments
12.6 Beijing Beigene
12.6.1 Company Information
12.6.2 Anti-PD-1 MAb Product Offered
12.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Beijing Beigene Latest Developments
...

13 Research Findings and Conclusion

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Anti-PD-1 MAb Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of 40mg
Table 5. Major Players of 100mg
Table 6. Major Players of 200mg
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Table 10. Global Anti-PD-1 MAb Revenue by Type (2015-2020) ($ million)
Table 11. Global Anti-PD-1 MAb Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Anti-PD-1 MAb Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Table 15. Global Anti-PD-1 MAb Value by Application (2015-2020)
Table 16. Global Anti-PD-1 MAb Value Market Share by Application (2015-2020)
Table 17. Global Anti-PD-1 MAb Sale Price by Application (2015-2020)
Table 18. Global Anti-PD-1 MAb Sales by Company (2017-2019) (KG)
Table 19. Global Anti-PD-1 MAb Sales Market Share by Company (2017-2019)
Table 20. Global Anti-PD-1 MAb Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Anti-PD-1 MAb Revenue Market Share by Company (2017-2019)
Table 22. Global Anti-PD-1 MAb Sale Price by Company (2017-2019)
Table 23. Global Anti-PD-1 MAb Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Anti-PD-1 MAb Products Offered
Table 25. Anti-PD-1 MAb Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Anti-PD-1 MAb Consumption by Regions 2015-2020 (KG)
Table 27. Global Anti-PD-1 MAb Consumption Market Share by Regions 2015-2020
Table 28. Global Anti-PD-1 MAb Value by Regions 2015-2020 ($ Millions)
Table 29. Global Anti-PD-1 MAb Value Market Share by Regions 2015-2020
Table 30. Americas Anti-PD-1 MAb Consumption by Countries (2015-2020) (KG)
Table 31. Americas Anti-PD-1 MAb Consumption Market Share by Countries (2015-2020)
Table 32. Americas Anti-PD-1 MAb Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Anti-PD-1 MAb Value Market Share by Countries (2015-2020)
Table 34. Americas Anti-PD-1 MAb Consumption by Type (2015-2020) (KG)
Table 35. Americas Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Table 36. Americas Anti-PD-1 MAb Consumption by Application (2015-2020) (KG)
Table 37. Americas Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Table 38. APAC Anti-PD-1 MAb Consumption by Countries (2015-2020) (KG)
Table 39. APAC Anti-PD-1 MAb Consumption Market Share by Countries (2015-2020)
Table 40. APAC Anti-PD-1 MAb Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Anti-PD-1 MAb Value Market Share by Regions (2015-2020)
Table 42. APAC Anti-PD-1 MAb Consumption by Type (2015-2020) (KG)
Table 43. APAC Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Table 44. APAC Anti-PD-1 MAb Consumption by Application (2015-2020) (KG)
Table 45. APAC Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Table 46. Europe Anti-PD-1 MAb Consumption by Countries (2015-2020) (KG)
Table 47. Europe Anti-PD-1 MAb Consumption Market Share by Countries (2015-2020)
Table 48. Europe Anti-PD-1 MAb Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Anti-PD-1 MAb Value Market Share by Countries (2015-2020)
Table 50. Europe Anti-PD-1 MAb Consumption by Type (2015-2020) (KG)
Table 51. Europe Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Table 52. Europe Anti-PD-1 MAb Consumption by Application (2015-2020) (KG)
Table 53. Europe Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Anti-PD-1 MAb Consumption by Countries (2015-2020) (KG)
Table 55. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Anti-PD-1 MAb Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Anti-PD-1 MAb Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Anti-PD-1 MAb Consumption by Type (2015-2020) (KG)
Table 59. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Anti-PD-1 MAb Consumption by Application (2015-2020) (KG)
Table 61. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Table 62. Anti-PD-1 MAb Distributors List
Table 63. Anti-PD-1 MAb Customer List
Table 64. Global Anti-PD-1 MAb Consumption Forecast by Countries (2021-2025) (KG)
Table 65. Global Anti-PD-1 MAb Consumption Market Forecast by Regions
Table 66. Global Anti-PD-1 MAb Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Anti-PD-1 MAb Value Market Share Forecast by Regions
Table 68. Global Anti-PD-1 MAb Consumption Forecast by Type (2021-2025) (KG)
Table 69. Global Anti-PD-1 MAb Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Anti-PD-1 MAb Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Anti-PD-1 MAb Value Market Share Forecast by Type (2021-2025)
Table 72. Global Anti-PD-1 MAb Consumption Forecast by Application (2021-2025) (KG)
Table 73. Global Anti-PD-1 MAb Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Anti-PD-1 MAb Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Anti-PD-1 MAb Value Market Share Forecast by Application (2021-2025)
Table 76. Bristol Myers Squibb Product Offered
Table 77. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 78. Bristol Myers Squibb Main Business
Table 79. Bristol Myers Squibb Latest Developments
Table 80. Bristol Myers Squibb Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Product Offered
Table 82. Merck Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Merck Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 86. Innovent Biologics Inc Product Offered
Table 87. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 88. Innovent Biologics Inc Main Business
Table 89. Innovent Biologics Inc Latest Developments
Table 90. Innovent Biologics Inc Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 91. Hengrui Medicine Product Offered
Table 92. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 93. Hengrui Medicine Main Business
Table 94. Hengrui Medicine Latest Developments
Table 95. Hengrui Medicine Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 96. Junshi Pharma Product Offered
Table 97. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 98. Junshi Pharma Main Business
Table 99. Junshi Pharma Latest Developments
Table 100. Junshi Pharma Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 101. Beijing Beigene Product Offered
Table 102. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2020E)
Table 103. Beijing Beigene Main Business
Table 104. Beijing Beigene Latest Developments
Table 105. Beijing Beigene Basic Information, Company Total Revenue (in $ million), Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Anti-PD-1 MAb
Figure 2. Anti-PD-1 MAb Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Anti-PD-1 MAb Consumption Growth Rate 2015-2025 (KG)
Figure 5. Global Anti-PD-1 MAb Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 40mg
Figure 7. Product Picture of 100mg
Figure 8. Product Picture of 200mg
Figure 9. Product Picture of Others
Figure 10. Global Anti-PD-1 MAb Consumption Market Share by Type (2015-2020)
Figure 11. Global Anti-PD-1 MAb Value Market Share by Type (2015-2020)
Figure 12. Anti-PD-1 MAb Consumed in Melanoma Patients
Figure 13. Global Anti-PD-1 MAb Market: Melanoma Patients (2015-2020) (KG)
Figure 14. Global Anti-PD-1 MAb Market: Melanoma Patients (2015-2020) ($ Millions)
Figure 15. Anti-PD-1 MAb Consumed in Lung Cancer Patients
Figure 16. Global Anti-PD-1 MAb Market: Lung Cancer Patients (2015-2020) (KG)
Figure 17. Global Anti-PD-1 MAb Market: Lung Cancer Patients (2015-2020) ($ Millions)
Figure 18. Anti-PD-1 MAb Consumed in Lymphoma Patients
Figure 19. Global Anti-PD-1 MAb Market: Lymphoma Patients (2015-2020) (KG)
Figure 20. Global Anti-PD-1 MAb Market: Lymphoma Patients (2015-2020) ($ Millions)
Figure 21. Anti-PD-1 MAb Consumed in Other
Figure 22. Global Anti-PD-1 MAb Market: Other (2015-2020) (KG)
Figure 23. Global Anti-PD-1 MAb Market: Other (2015-2020) ($ Millions)
Figure 24. Global Anti-PD-1 MAb Consumption Market Share by Application (2015-2020)
Figure 25. Global Anti-PD-1 MAb Value Market Share by Application (2015-2020)
Figure 26. Global Anti-PD-1 MAb Sales Market Share by Company in 2017
Figure 27. Global Anti-PD-1 MAb Sales Market Share by Company in 2019
Figure 28. Global Anti-PD-1 MAb Revenue Market Share by Company in 2017
Figure 29. Global Anti-PD-1 MAb Revenue Market Share by Company in 2019
Figure 30. Global Anti-PD-1 MAb Sale Price by Company in 2019
Figure 31. Global Anti-PD-1 MAb Consumption Market Share by Regions 2015-2020
Figure 32. Global Anti-PD-1 MAb Value Market Share by Regions 2015-2020
Figure 33. Americas Anti-PD-1 MAb Consumption 2015-2020 (KG)
Figure 34. Americas Anti-PD-1 MAb Value 2015-2020 ($ Millions)
Figure 35. APAC Anti-PD-1 MAb Consumption 2015-2020 (KG)
Figure 36. APAC Anti-PD-1 MAb Value 2015-2020 ($ Millions)
Figure 37. Europe Anti-PD-1 MAb Consumption 2015-2020 (KG)
Figure 38. Europe Anti-PD-1 MAb Value 2015-2020 ($ Millions)
Figure 39. Middle East & Africa Anti-PD-1 MAb Consumption 2015-2020 (KG)
Figure 40. Middle East & Africa Anti-PD-1 MAb Value 2015-2020 ($ Millions)
Figure 41. Americas Anti-PD-1 MAb Consumption Market Share by Countries in 2019
Figure 42. Americas Anti-PD-1 MAb Value Market Share by Countries in 2019
Figure 43. Americas Anti-PD-1 MAb Consumption Market Share by Type in 2019
Figure 44. Americas Anti-PD-1 MAb Consumption Market Share by Application in 2019
Figure 45. United States Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 46. United States Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 47. Canada Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 48. Canada Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 49. Mexico Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 50. Mexico Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 51. APAC Anti-PD-1 MAb Consumption Market Share by Countries in 2019
Figure 52. APAC Anti-PD-1 MAb Value Market Share by Regions in 2019
Figure 53. APAC Anti-PD-1 MAb Consumption Market Share by Type in 2019
Figure 54. APAC Anti-PD-1 MAb Consumption Market Share by Application in 2019
Figure 55. China Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 56. China Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 57. Japan Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 58. Japan Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 59. Korea Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 60. Korea Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 61. Southeast Asia Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 62. Southeast Asia Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 63. India Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 64. India Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 65. Australia Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 66. Australia Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 67. Europe Anti-PD-1 MAb Consumption Market Share by Countries in 2019
Figure 68. Europe Anti-PD-1 MAb Value Market Share by Countries in 2019
Figure 69. Europe Anti-PD-1 MAb Consumption Market Share by Type in 2019
Figure 70. Europe Anti-PD-1 MAb Consumption Market Share by Application in 2019
Figure 71. Germany Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 72. Germany Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 73. France Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 74. France Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 75. UK Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 76. UK Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 77. Italy Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 78. Italy Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 79. Russia Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 80. Russia Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 81. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Countries in 2019
Figure 82. Middle East & Africa Anti-PD-1 MAb Value Market Share by Countries in 2019
Figure 83. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Type in 2019
Figure 84. Middle East & Africa Anti-PD-1 MAb Consumption Market Share by Application in 2019
Figure 85. Egypt Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 86. Egypt Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 87. South Africa Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 88. South Africa Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 89. Israel Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 90. Israel Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 91. Turkey Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 92. Turkey Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 93. GCC Countries Anti-PD-1 MAb Consumption Growth 2015-2020 (KG)
Figure 94. GCC Countries Anti-PD-1 MAb Value Growth 2015-2020 ($ Millions)
Figure 95. Global Anti-PD-1 MAb Consumption Growth Rate Forecast (2021-2025) (KG)
Figure 96. Global Anti-PD-1 MAb Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 97. Americas Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 98. Americas Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 99. APAC Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 100. APAC Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 101. Europe Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 102. Europe Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 103. Middle East & Africa Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 104. Middle East & Africa Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 105. United States Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 106. United States Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 107. Canada Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 108. Canada Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 109. Mexico Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 110. Mexico Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 111. Brazil Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 112. Brazil Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 113. China Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 114. China Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 115. Japan Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 116. Japan Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 117. Korea Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 118. Korea Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 119. Southeast Asia Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 120. Southeast Asia Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 121. India Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 122. India Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 123. Australia Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 124. Australia Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 125. Germany Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 126. Germany Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 127. France Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 128. France Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 129. UK Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 130. UK Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 131. Italy Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 132. Italy Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 133. Russia Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 134. Russia Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 135. Spain Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 136. Spain Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 137. Egypt Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 138. Egypt Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 139. South Africa Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 140. South Africa Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 141. Israel Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 142. Israel Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 143. Turkey Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 144. Turkey Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 145. GCC Countries Anti-PD-1 MAb Consumption 2021-2025 (KG)
Figure 146. GCC Countries Anti-PD-1 MAb Value 2021-2025 ($ Millions)
Figure 147. Bristol Myers Squibb Anti-PD-1 MAb Market Share (2018-2020)
Figure 148. Merck Anti-PD-1 MAb Market Share (2018-2020)
Figure 149. Innovent Biologics Inc Anti-PD-1 MAb Market Share (2018-2020)
Figure 150. Hengrui Medicine Anti-PD-1 MAb Market Share (2018-2020)
Figure 151. Junshi Pharma Anti-PD-1 MAb Market Share (2018-2020)
Figure 152. Beijing Beigene Anti-PD-1 MAb Market Share (2018-2020)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3660
USD $5490
USD $7320
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.